Press release
Strategic Forecast for the Pediatric Clinical Trials Industry: Market Outlook 2025-2034
Pediatric Clinical Trials
Pediatric Clinical Trials Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the pediatric clinical trials market has witnessed a robust growth. The market, which stood at $17.41 billion in 2024, is projected to reach $18.45 billion in 2025, representing a compound annual growth rate (CAGR) of 6.0%. The significant expansion during the historical phase is largely credited to regulatory incentives, unsatisfied medical needs, the progress in pediatric medicine, initiatives aimed at global public health, ethical obligations, and programs for pediatric vaccination.
How Will the Pediatric Clinical Trials Market Size Evolve and Grow by 2029?
In the coming years, the market size for pediatric clinical trials is predicted to experience robust expansion. The projected growth is to reach "$24.8 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the forecast period include the incorporation of real-world evidence, the discovery of pediatric biomarkers, broadened access programs, research into pediatric infectious diseases, and advancements in pediatric cardiology. Key trends projected for this period comprise patient-focused trial designs, the embrace of adaptive trial methods, the use of digital health technologies, global cooperation, and consortia, as well as improvements in pediatric oncology.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report
What Drivers Are Propelling the Growth of Pediatric Clinical Trials Market Forward?
The pediatric clinical trials market is set to benefit from an increase in pediatric cancer occurrences. Children and young adolescents under 14 can develop pediatric cancers, which are relatively rare and may differ in terms of growth and spread from adult cancer types. The importance of pediatric clinical trials in improving diagnosis and treatment continues to grow. For example, the American Cancer Society, a voluntary healthcare organization based in the United States, forecasts that around 9,910 children younger than 15 in the US will be diagnosed with cancer in January 2023. Additionally, it predicts that approximately 1,040 children below 15 years of age will succumb to the disease the same year. Thus, the escalating healthcare expenditure is contributing to the growth of the pediatric clinical trials market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp
Which Emerging Trends Are Transforming the Pediatric Clinical Trials Market in 2025?
The pediatric clinical trial market is being shaped by innovative research models. In June 2022, US-based Leukemia & Lymphoma Society launched the PedAL Master Clinical Trial, which tailors leukemia treatments to each child's unique tumor biology, aiming for more personalized and effective outcomes.
What Are the Key Segments in the Pediatric Clinical Trials Market?
The pediatric clinical trials market covered in this report is segmented -
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Treatment Studies, Observational Studies
3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas
Subsegments:
1) By Phase I: First-in-Pediatrics Trials, Dose Escalation Studies, Safety And Tolerability Assessments
2) By Phase II: Efficacy Studies, Dose Optimization Trials, Pharmacokinetic Studies
3) By Phase III: Large-Scale Efficacy Trials, Comparative Studies, Long-Term Safety Studies
4) By Phase IV: Post- marketing Surveillance, Long-Term Safety Monitoring, Effectiveness Studies In Real-World Settings
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10350&type=smp
Who Are the Key Players Shaping the Pediatric Clinical Trials Market's Competitive Landscape?
Major companies operating in the pediatric clinical trials market include Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp - Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences
What Geographic Markets Are Powering Growth in the Pediatric Clinical Trials Market?
North America was the largest region in the pediatric clinical trials market in 2024. The regions covered in the pediatric clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10350
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strategic Forecast for the Pediatric Clinical Trials Industry: Market Outlook 2025-2034 here
News-ID: 4096906 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
